Diagnose Smarter

AI-driven brain neuropathology diagnostics built to enhance today’s medical imaging

—No new hardware, no compromises.

Featured Products

SIENNA

Lightweight AI tool for brain tumor classification.

Aurora

AI-powered brain tumor diagnostics software for glioblastoma and metastasized tumor diagnostics.

Aetheria

State-of-the-art cancer diagnostics tool with vision transformers.

Our Services

AI Integration Suite

We integrate our state-of-the-art AI diagnostics into clinics and hospitals.

AI Training

We train radiologists, clinicians, neurologists, and students for integrating AI into their daily workflow.

AI Consultation

We consult with our clients to develop custom AI tools for their diagnostic needs.

About
our company

ITrakNeuro Inc. is a mission-driven startup pioneering deep learning artificial intelligence tools for the assessment and analysis of prominent and rare neurodegenerative diseases of the brain. We specialize in the intersection of neuroscience, medical imaging (including MRI), computer vision, and next-generation AI approaches, including high transferability of generalizable AGI-inspired models. Our goal is to accelerate diagnosis, streamline and optimize clinical workflow and patient care, and enable high-accuracy early interventions for patients. Our SIENNA technology accelerates tumor diagnostics and streamlines workflow for actionable outcomes and enables expandable applications in multiple areas of clinical medicine and workflow, including clinical workforce education and clinical trial prescreening.

At ITrakNeuro Inc., we are redefining how brain neuropathologies, such as cancers, are detected and monitored with our SIENNA technology. We bring cutting-edge, lightweight AI directly to clinics and hospitals without the need for costly hardware upgrades. Based in Albany, New York and incorporated in Delaware, our mission is to make high-accuracy brain imaging diagnostics accessible, efficient, and sustainable for every healthcare setting.

Our AI companion for cancer, SIENNA technology, is designed to identify tumor types, such as distinguishing prominent glioblastomas and metastasized tumors, with exceptional accuracy across a wide range of complex patient demographics, as well as MRI field strengths and MRI machine manufacturers. With the capability to use extraordinarily fewer trainable parameters, our models offer ultra-low energy consumption and run seamlessly on everyday computers and tablets, as well as enabling new exploration into rare diseases with small datasets.

Whether in a major hospital or a remote clinic, ITrakNeuro Inc. empowers you with dependable, generalizable AI diagnostics that adapt to your environment, not the other way around.

No new hardware. No heavy computation. Just intelligent care.